Benefit of adjuvant systemic therapies in HR+ HER2- pT1ab node-negative breast carcinomasA. De Nonneville,A. Gonçalves,J.-M. Boher,J.-M. Classe,M. Cohen,P.-E. Colombo,F. Reyal,M.-P. Chauvet,E. Jouve,E. Darai, G. Blache,C. Coutant,P. Gimbergues,C. Mazouni,R. Rouzier,R. Villet,P. Crochet,A.-S. Azuar,E. Lambaudie, G. HouvenaeghelAnnals of Oncology(2018)引用 0|浏览2暂无评分AI 理解论文溯源树样例生成溯源树,研究论文发展脉络Chat Paper正在生成论文摘要